Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Hannah Ewald, Marilia Santini-Oliveira, Julian-Emanuel Bühler, Danielle Vuichard, Stefan Schandelmaier, Marcel Stöckle, Matthias Briel, Heiner C. Bucher & Lars G. Hemkens. (2017) Comparative effectiveness of tenofovir in HIV-infected treatment-experienced patients: systematic review and meta-analysis. HIV Clinical Trials 18:1, pages 17-27.
Read now
Read now
Roger Bedimo, Lisa Rosenblatt & Joel Myers. (2016) Systematic review of renal and bone safety of the antiretroviral regimen efavirenz, emtricitabine, and tenofovir disoproxil fumarate in patients with HIV infection. HIV Clinical Trials 17:6, pages 246-266.
Read now
Read now
Articles from other publishers (20)
Jingjing Lang, Xin Xin, Panpan Chen, Zhen Ning & Shaotan Xiao. (2023) Distinct patterns of fasting plasma glucose and lipid profile levels over time in adults tested positive for HIV on HAART in Shanghai, China, revealed using growth mixture models. Frontiers in Medicine 9.
Crossref
Crossref
Chunling Yang, Dongli Wang, Yanmin Ma, Zhibin Liu, Huijun Guo, Feng Sang, Qianlei Xu & Yantao Jin. (2022) Effectors of Hyperlipidemia Among Patients with HIV/AIDS Taking
Second-line Antiretroviral Therapy Based on Registry Data. Current HIV Research 20:5, pages 373-379.
Crossref
Crossref
Laurence Brunet, Patrick Mallon, Jennifer S. Fusco, Michael B. Wohlfeiler, Girish Prajapati, Andrew Beyer & Gregory P. Fusco. (2021) Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living with HIV: Lipid Changes and Statin Underutilization. Clinical Drug Investigation 41:11, pages 955-965.
Crossref
Crossref
R Hsu, L Brunet, J Fusco, A Beyer, G Prajapati, C Wyatt, M Wohlfeiler & G Fusco. (2020) Risk of chronic kidney disease in people living with HIV by tenofovir disoproxil fumarate (TDF) use and baseline D:A:D chronic kidney disease risk score. HIV Medicine 22:5, pages 325-333.
Crossref
Crossref
Aoife Lacey, Stefano Savinelli, Elena Alvarez Barco, Alan Macken, Aoife G. Cotter, Gerard Sheehan, John S. Lambert, Eavan Muldoon, Eoin Feeney, Patrick W. Mallon & Willard Tinago. (2020) Investigating the effect of antiretroviral switch to tenofovir alafenamide on lipid profiles in people living with HIV. AIDS 34:8, pages 1161-1170.
Crossref
Crossref
Jessica Cusato, Andrea Calcagno, Letizia Marinaro, Valeria Avataneo, Antonio DʹAvolio, Giovanni Di Perri & Stefano Bonora. (2019) Pharmacogenetic determinants of kidney-associated urinary and serum abnormalities in antiretroviral-treated HIV-positive patients. The Pharmacogenomics Journal 20:2, pages 202-212.
Crossref
Crossref
Yinzhong Shen, Tingyi Liu, Jun Chen, Xin Li, Li Liu, Jiayin Shen, Jiangrong Wang, Renfang Zhang, Meiyan Sun, Zhenyan Wang, Wei Song, Tangkai Qi, Yang Tang, Xianmin Meng, Lijun Zhang, Dean Ho, Chih‐Ming Ho, Xianting Ding & Hong‐Zhou Lu. (2019) Harnessing Artificial Intelligence to Optimize Long‐Term Maintenance Dosing for Antiretroviral‐Naive Adults with HIV‐1 Infection. Advanced Therapeutics 3:4, pages 1900114.
Crossref
Crossref
A. B. Astrowskaja, R. I. Krauchuk & M. M. Kurbat. (2020) Features of liver ultrastructure of rat exposed by antiretroviral drug tenofovir disoproxil fumarate in combination with S-adenosylmethionine. Proceedings of the National Academy of Sciences of Belarus, Medical series 17:1, pages 55-63.
Crossref
Crossref
Li-Qin Sun, Jia-Ye Liu, Yun He, Yang Zhou, Liu-Mei Xu, Lu-Kun Zhang, Fang Zhao, Xiao-Ning Liu, Ying Song, Ting-Zhi Cao, Yi-Mei Tian, Man Rao & Hui Wang. (2020) Evolution of blood lipids and risk factors of dyslipidemia among people living with human immunodeficiency virus who had received first-line antiretroviral regimens for 3 years in Shenzhen. Chinese Medical Journal 133:23, pages 2808-2815.
Crossref
Crossref
Qi Feng, Aoshuang Zhou, Huachun Zou, Suzanne Ingle, Margaret T May, Weiping Cai, Chien-Yu Cheng, Zuyao Yang & Jinling Tang. (2019) Quadruple versus triple combination antiretroviral therapies for treatment naive people with HIV: systematic review and meta-analysis of randomised controlled trials. BMJ, pages l4179.
Crossref
Crossref
Junyang Yang, Jun Chen, Yongjia Ji, Qi Tang, Renfang Zhang, Li Liu, Yinzhong Shen, Jingna Xun, Wei Song, Yang Tang, Zhenyan Wang, Tangkai Qi & Hongzhou Lu. (2019) Lipid profile and renal safety of tenofovir disoproxil fumarate-based anti-retroviral therapy in HIV-infected Chinese patients. International Journal of Infectious Diseases 83, pages 64-71.
Crossref
Crossref
P Bock, K Nel, G Fatti, R Sloot, N Ford, J Voget, C Gunst, N Grobbelaar, F Louis, S Floyd, R Hayes, H Ayles, N Beyers & S Fidler. (2019)
Renal dysfunction by baseline
CD
4 cell count in a cohort of adults starting antiretroviral treatment regardless of
CD
4 count in the HIV Prevention Trials Network 071 [
HPTN 071
; Population Effect of Antiretroviral Therapy to Reduce HIV Transmission (Pop
ART
)] study in South Africa
. HIV Medicine.
Crossref
Crossref
Willem Daniel Francois Venter, Andrew Kambugu, Matthew F. Chersich, Stephen Becker, Andrew Hill, Natasha Arulappan, Michelle Moorhouse, Mohammed Majam, Godspower Akpomiemie, Simiso Sokhela, Selvamuthu Poongulali, Charles Feldman, Chris Duncombe, David H. Brown Ripin, Alinda Vos & Nagalingeswaran Kumarasamy. (2019) Efficacy and Safety of Tenofovir Disoproxil Fumarate Versus Low-Dose Stavudine Over 96 Weeks: A Multicountry Randomized, Noninferiority Trial. JAIDS Journal of Acquired Immune Deficiency Syndromes 80:2, pages 224-233.
Crossref
Crossref
Joanne LaFleur, Adam P. Bress, Stephen Esker, Kristin Knippenberg, Jacob Crook, Heather Nyman, Roger Bedimo, Pablo Tebas & Lisa Rosenblatt. (2018) Brief Report: Tenofovir-Associated Nephrotoxicity Among a US National Historical Cohort of HIV-Infected Veterans: Risk Modification by Concomitant Antiretrovirals. JAIDS Journal of Acquired Immune Deficiency Syndromes 77:3, pages 325-330.
Crossref
Crossref
Jessica Cusato, Sarah Allegra, Amedeo De Nicolò, Andrea Calcagno & Antonio D'Avolio. (2018) Precision medicine for HIV: where are we?. Pharmacogenomics 19:2, pages 145-165.
Crossref
Crossref
S. E. Salvaggio, A. Giacomelli, F. S. Falvella, M. L. Oreni, P. Meraviglia, C. Atzori, E. G. I. Clementi, M. Galli & S. Rusconi. (2017) Clinical and genetic factors associated with kidney tubular dysfunction in a real-life single centre cohort of HIV-positive patients. BMC Infectious Diseases 17:1.
Crossref
Crossref
Silvia Nozza, Andrea Malagoli, Lilian Maia, Andrea Calcagno, Emanuele Focà, Giuseppe De Socio, Stefania Piconi, Giancarlo Orofino, Anna Maria Cattelan, Benedetto Maurizio Celesia, Elena Gervasi, Giovanni Guaraldi, Silvia Nozza, Antonella Castagna, Andrea Poli, Nadia Galizzi, Giovanni Guaraldi, Federica Carli, Andrea Malagoli, Andrea Calcagno, Giovanni Di Perri, Stefano Bonora, Chiara Montrucchio, Emanuele Focà, Francesco Castelli, Paola Magro, Eugenia Quiros Roldan, Giuseppe Vittorio De Socio, Serena Marinello, Stefania Piconi, Giancarlo Orofino, Mariana Farenga, Anna Maria Cattela, Serena Marinello, Benedetto Maurizio Celesia, Andrea Marino, Bruno Cacopardo, Massimo Galli, Agostino Riva, Valeria Morena & Elena Gervasi. (2017) Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study. Journal of Antimicrobial Chemotherapy 72:10, pages 2879-2886.
Crossref
Crossref
Kyoung Hwa LeeJi Un LeeNam Su KuSu Jin JeongSang Hoon HanJun Yong ChoiYoung Goo SongJune Myung Kim. (2017) Change in Renal Function among HIV-Infected Koreans Receiving Tenofovir Disoproxil Fumarate-Backbone Antiretroviral Therapy: A 3-Year Follow-Up Study. Yonsei Medical Journal 58:4, pages 770.
Crossref
Crossref
Zhongbao Zuo, Shu Liang, Xianguang Sun, Scottie Bussell, Jing Yan, Wei Kan, Xuebing Leng, Lingjie Liao, Yuhua Ruan, Yiming Shao & Hui Xing. (2016) Drug Resistance and Virological Failure among HIV-Infected Patients after a Decade of Antiretroviral Treatment Expansion in Eight Provinces of China. PLOS ONE 11:12, pages e0166661.
Crossref
Crossref
Ella T. Nkhoma, Lisa Rosenblatt, Joel Myers, Angelina Villasis-Keever & John Coumbis. (2016) Real-World Assessment of Renal and Bone Safety among Patients with HIV Infection Exposed to Tenofovir Disoproxil Fumarate-Containing Single-Tablet Regimens. PLOS ONE 11:12, pages e0166982.
Crossref
Crossref